Back to overview

Highlights in kidney cancer treatment

We spoke to Prof. Marc-Oliver Grimm (Jena, DE) on the topic of Renal Cell Cancer and what delegates could expect from EAU21. Prof. Grimm is co-chairing Plenary Session 4 “Renal cancer: from localised to metastatic” with Profs. Capitanio and Mulders. Plenary session 4 will take place on Saturday 10 July, from 11:00 – 12:30 and will include the hottest topics to do with RCC. Further sessions will delve into RCC as well, including several of Saturday’s Poster Sessions.

“Renal cell cancer (RCC) is evolving rapidly with regard to molecular, diagnostic and treatment research and its implementation in clinical practice,” said Grimm. “The VHL mechanism in RCC is a good example and all its aspects will be discussed to set the scene of this session. This is a special lecture on behalf of the Society of Urologic Oncology (SUO). For the small renal mass, an update will be given on different approaches and will help you to make the right decision.”

“In larger tumours there has recently been a shift in surgery towards more nephron sparing. A pro and con discussion on this issue will help delegates finetune their clinical practice. In the mRCC setting prospective randomised trials tried to answer the role of nephrectomy in different eras of systemic therapy.”

“The choice can be individualised and is also dependent on new treatment possibilities. Look forward to a mix of pre-recorded lectures by experts and interactive live discussion led by the session chairmen.”